HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andreas G Niethammer Selected Research

Breast Neoplasms (Breast Cancer)

7/2006Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andreas G Niethammer Research Topics

Disease

14Neoplasms (Cancer)
04/2015 - 07/2002
5Neoplasm Metastasis (Metastasis)
04/2008 - 12/2002
4Melanoma (Melanoma, Malignant)
12/2011 - 12/2002
2Inflammation (Inflammations)
01/2022 - 03/2014
2Pancreatic Neoplasms (Pancreatic Cancer)
04/2015 - 08/2012
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2014 - 06/2004
2Carcinoma (Carcinomatosis)
04/2008 - 12/2002
1Body Weight (Weight, Body)
01/2022
1Obesity
01/2022
1Hypertension (High Blood Pressure)
04/2014
1Fatigue
04/2014
1Neutropenia
03/2014
1Renal Cell Carcinoma (Grawitz Tumor)
03/2014
1Pneumonia (Pneumonitis)
03/2014
1Stomatitis
03/2014
1Hyperglycemia
03/2014
1Hypercholesterolemia
03/2014
1Hypophosphatemia
03/2014
1Atherosclerosis
09/2007
1Cardiovascular Diseases (Cardiovascular Disease)
09/2007
1Rectal Neoplasms (Rectal Cancer)
11/2006
1Breast Neoplasms (Breast Cancer)
07/2006
1Sarcoma (Soft Tissue Sarcoma)
04/2006
1Pathologic Constriction (Stenosis)
01/2006
1Radiation Injuries (Radiation Sickness)
09/2005
1T-Cell Leukemia (Leukemia, T Cell)
07/2003
1Leukemia
07/2003

Drug/Important Bio-Agent (IBA)

7VaccinesIBA
04/2015 - 12/2002
5Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
04/2015 - 12/2002
4DNA VaccinesIBA
04/2008 - 12/2002
4AutoantigensIBA
04/2008 - 07/2002
3Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
04/2015 - 12/2002
3Pharmaceutical PreparationsIBA
07/2006 - 07/2003
2Axitinib (AG 013736)IBA
04/2014 - 12/2011
2AntigensIBA
04/2008 - 01/2005
2DNA (Deoxyribonucleic Acid)IBA
04/2008 - 09/2007
2Proteins (Proteins, Gene)FDA Link
07/2006 - 01/2005
1CytokinesIBA
01/2022
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2015
1CollagenIBA
04/2015
1Biomarkers (Surrogate Marker)IBA
04/2015
1Cisplatin (Platino)FDA LinkGeneric
04/2014
1Pemetrexed (MTA)FDA Link
04/2014
1Interferon-alpha (Interferon Alfa)IBA
03/2014
1Bevacizumab (Avastin)FDA Link
03/2014
1temsirolimusFDA Link
03/2014
1asparaginylendopeptidase (legumain)IBA
04/2008
1Collagen Type I (Type I Collagen)IBA
07/2006
1Integrin beta3 (GPIIIa)IBA
09/2005
1arginyl-glycyl-glutamic acidIBA
09/2005
1PeptidomimeticsIBA
09/2005
1IntegrinsIBA
09/2005
1ProdrugsIBA
07/2003
1Etoposide (VP 16)FDA LinkGeneric
07/2003
1A-Form DNA (A-DNA)IBA
12/2002

Therapy/Procedure

6Therapeutics
03/2014 - 12/2002
4Radiotherapy
11/2006 - 09/2005
4Immunotherapy
07/2006 - 07/2002
3Drug Therapy (Chemotherapy)
11/2006 - 01/2005
1Oral Administration
01/2022
1Nephrectomy
03/2014